Jump to main content
Jump to site search

Issue 8, 2014
Previous Article Next Article

Pyrazolylbenzyltriazoles as cyclooxygenase inhibitors: synthesis and biological evaluation as dual anti-inflammatory and antimicrobial agents

Author affiliations

Abstract

A series of pyrazolylbenzyltriazoles as celecoxib analogues having a 1,5-diaryl relationship as potential leads for the development of molecular probes for imaging of COX-2 expression was prepared by the reaction of appropriate trifluoromethyl-β-diketones (12a–12i) with 1-[(4-hydrazinophen-1-yl)methyl]-1H-1,2,4-triazole hydrochloride in refluxing ethanol. All compounds were screened for in vitro cyclooxygenase (COX) assays to determine COX-1 and COX-2 inhibitory potency. Moreover, the anti-inflammatory activity of selected compounds, which are the most selective COX-2 inhibitors in the COX inhibition assay, was investigated in vivo using a carrageenan-induced rat paw edema model. Four compounds 13b, 13e, 13g and 13h were found to be the most potent selective COX-2 inhibitors of this study with 13h showing the best COX-2 profile. Compounds 13b, 13c and 13h also showed promising anti-inflammatory (AI) activity at 5 h after the carrageenan injection that was comparable to that of the standard drug celecoxib. In addition to that, compounds were also evaluated for in vitro antimicrobial activity against two Gram-positive bacteria (Staphylococcus aureus, Bacillus subtilis), two Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa) and two fungal strains (Saccharomyces cerevisiae and Candida albicans). Most of the compounds exhibited moderate to excellent antibacterial activity against both Gram-positive pathogens and against one Gram negative species (Escherichia coli). The selective COX-2 inhibitory activity of compound 13h is significant and it could be employed as a dual anti-inflammatory and antibacterial drug. Therefore, these compounds would represent a fruitful matrix for the development of dual anti-inflammatory antimicrobial candidates with significant COX activity.

Graphical abstract: Pyrazolylbenzyltriazoles as cyclooxygenase inhibitors: synthesis and biological evaluation as dual anti-inflammatory and antimicrobial agents

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 Feb 2014, accepted on 20 May 2014 and first published on 22 May 2014


Article type: Paper
DOI: 10.1039/C4NJ00226A
New J. Chem., 2014,38, 3662-3672

  •   Request permissions

    Pyrazolylbenzyltriazoles as cyclooxygenase inhibitors: synthesis and biological evaluation as dual anti-inflammatory and antimicrobial agents

    N. Chandna, J. K. Kapoor, J. Grover, K. Bairwa, V. Goyal and S. M. Jachak, New J. Chem., 2014, 38, 3662
    DOI: 10.1039/C4NJ00226A

Search articles by author

Spotlight

Advertisements